Tweetovi

Blokirali ste korisnika/cu @AdamDakin

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AdamDakin

  1. proslijedio/la je Tweet
    28. sij

    Congrats co on being named a Global 100 company for 2020! cc

    Poništi
  2. 8. sij
    Poništi
  3. proslijedio/la je Tweet
    5. sij

    Our team will be at meeting and startups, giving advice, & talking about our Spring 2020 program. Grab a time to meet with Managing Director of Investments- - or our Healthtech PM Ethan Wergelis-Isaacson:

    Poništi
  4. 31. pro 2019.

    We are truly fortunate to have healthtech thought leaders like as advisors and supporters.

    Poništi
  5. proslijedio/la je Tweet
    19. pro 2019.

    🏥Applications are open for our Spring 2020 Healthtech program, designed for , medical device, and diagnostics companies with revenue, pilots, or early traction. Gain customers, raise capital, and scale your startup. 📈 cc

    Poništi
  6. proslijedio/la je Tweet
    11. pro 2019.

    🏥Digital health & medical device startups: 📜Applications are open for our Spring 2020 Healthtech program. Designed for startups with revenue/pilots, the program helps startups gain customers, scale up, & raise capital. Learn more: cc

    Poništi
  7. proslijedio/la je Tweet
    3. pro 2019.

    It’s here! The Podcast. Tune in to hear episode #1 where and discuss everything from his new role at to why he is so bullish on unbundling medicine.

    Poništi
  8. proslijedio/la je Tweet
    18. stu 2019.

    Thanks for recognizing our Healthtech program as one of the top digital health accelerators! Applications are now open for our next cohort of healthtech startups:

    Poništi
  9. proslijedio/la je Tweet
    12. stu 2019.

    Are you a founder considering raising a bridge round? In our today, we'll discuss issues that arise when raising bridge rounds and common mistakes that founders make when raising this type of round. RSVP here:

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    6. stu 2019.

    Join us for our next : will be speaking with startup lawyer Geoff Star about equity, cap tables, valuations, and other critical issues for early stage founders: RSVP here:

    Poništi
  11. 8. lis 2019.
    Poništi
  12. proslijedio/la je Tweet
    16. ruj 2019.
    Poništi
  13. 17. ruj 2019.

    Could not be more proud of Infermedica and Sana!

    Poništi
  14. proslijedio/la je Tweet
    14. kol 2019.

    Join us for a on Aug 15 @ 12 pm ET about "the 4 most common pitch mistakes founders make when fundraising." Healthtech experts & Ethan Wergelis-Isaacson will be discussing fundraising strategies & answering questions.

    Poništi
  15. 12. kol 2019.

    Go Epharmix! Awesome Dreamit alumni company.

    Poništi
  16. proslijedio/la je Tweet
    31. srp 2019.

    🎥Want to see how how the B2B startups in the Dreamit program gain customers and find new partners? Check out our new video on the "Customer Sprint" process: cc

    Poništi
  17. 17. srp 2019.

    My latest article: Insights on board management for healthcare startups from building trust to managing bad news

    Poništi
  18. proslijedio/la je Tweet
    9. srp 2019.

    We are looking for someone to join our team as a Content Marketing Associate. The ideal candidate will be a self-starter with fantastic writing skills who loves interacting with founders. Learn more about the role:

    Poništi
  19. proslijedio/la je Tweet
    19. lip 2019.

    8 minutes is enough for us to explain the benefits of using in companies. Join ’s live demo at DIA Amsterdam next week, and learn how to stand out from the crowd!

    Poništi
  20. proslijedio/la je Tweet
    19. lip 2019.

    In part II of Dreamit Healthtech Managing Director 's appearance on the MedTech Mindset Podcast, he discusses medtech funding trends and tips for success at the pitch table. Listen to it here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·